<DOC>
	<DOCNO>NCT00145574</DOCNO>
	<brief_summary>This study evaluate lipid-lowering effect safety colesevelam therapy administer heterozygous familial pediatric patient 10 17 year age stable dose pediatric-approved statin monotherapy ( atorvastatin , lovastatin , simvastatin pravastatin ) , treatment naive lipid-lowering therapy .</brief_summary>
	<brief_title>Efficacy Safety Colesevelam Pediatric Patients With Genetic High Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>Male female patient Ages 10 17 year inclusive Diagnosis heterozygous familial hypercholesterolemia On stable dose statin monotherapy treatment naive lipid lower agent On lowcholesterol diet Patients serious concomitant condition could interfere analysis result could interfere wellbeing patient</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>colesevelam</keyword>
</DOC>